UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: February 11, 2019
Accession Number:
Submission Type:
CIK: 0001042074
Company Name: CymaBay Therapeutics, Inc.
File Number: 333-229082